J. Passweg

Autologous Hemopoietic Stem Cell Transplantation in Severe Rheumatoid Arthritis: A Report from the EBMT and ABMTR (2004)

Snowden, JA, Passweg, J, Moore, JJ, Milliken, S, Cannell, P, Van Laar, JM, ...

Objective. Since 1996, autologous hemopoietic stem cell transplantation (HSCT) has been used to treat severe rheumatoid arthritis (RA). To date, published reports have been individual cases or series...

Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality (1999)

Tyndall, A., Fassas, A., Passweg, J., Attal, M., Brooks, P. M.

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

Binks, M, Passweg, J, Furst, D, McSweeney, P, Sullivan, K, Besenthal, C, ...

BACKGROUND—Systemic sclerosis (SSc, scleroderma) in either its diffuse or limited skin forms has a high mortality when vital organs are affected. No treatment has been shown to influence the...

Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000

Tyndall, A, Passweg, J, Gratwohl, A

An international meeting took place in Basel, Switzerland from 5 to 7 October 2000 involving 180 participants from 30 countries, with the aim of assessing the existing data on autologous...

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

Farge, D, Passweg, J, Van Laar, J M, Marjanovic, Z, Besenthal, C, Finke, J, ...

Objective: To analyse the durability of the responses after haematopoietic stem cell transplantation (HSCT) for severe systemic sclerosis (SSc) and determine whether the high transplant related...